Sonnet BioTherapeutics (SONN) Scheduled to Post Quarterly Earnings on Monday

Sonnet BioTherapeutics (NASDAQ:SONN – Get Free Report) is scheduled to release its earnings data on Monday, February 12th. Sonnet BioTherapeutics Price Performance SONN opened at $1.51 on Friday. Sonnet BioTherapeutics has a 52-week low of $1.08 and a 52-week high of $26.40. The business’s fifty day moving average is $1.50 and its 200-day moving average […]

Related Keywords

,Renaissance Technologies ,Boothbay Fund Management ,Sonnet Biotherapeutics Holdings Inc ,Sabby Management ,Get Free Report ,Street Corp ,Fund Management ,Funds Management ,Sonnet Biotherapeutics ,Nasdaq Sonn ,Sonn ,Medical ,Earnings ,